Animal models [electronic resource] : essential elements to address efficacy under the animal rule
- Bib ID:
- 4605895
- Format:
- Book
- Online Access:
- http://purl.access.gpo.gov/GPO/LPS111021
Broken link? let us search Trove , the Wayback Machine , or Google for you.
- Description:
-
- [Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2008]
- 15 p. : digital, PDF file.
- Technical Details:
- Mode of access: Internet at the FDA Web site. Address as of 4/06/09: http://www.fda.gov/cder/guidance/8324concept.pdf ; current access is available via PURL.
- Notes:
-
- Title from PDF title page (viewed on Apr. 6, 2009).
- "Concept paper."
- "September 2008."
- Includes bibliographical references (p. 15).
- Subject:
- Other authors/contributors:
- Also Titled:
- Essential elements to address efficacy under the animal rule
- Govt. Doc. Number:
- HE 20.4802:AN 5/2
- Copyright:
-
In Copyright
You may copy under some circumstances, for example you may copy a portion for research or study. Order a copy through Copies Direct to the extent allowed under fair dealing. Contact us for further information about copying.
- Reason for copyright status:
- Until 2078 [Created/Published Date + 70 Years]
Copyright status was determined using the following information:
- Material type:
- Literary Dramatic Musical
- Published status:
- Published
- Publication date:
- 2008
Copyright status may not be correct if data in the record is incomplete or inaccurate. Other access conditions may also apply. For more information please see: Copyright in library collections.
Feedback
Similar items
- Guidance for industry [electronic resource] : animal models : essential elements to address efficacy under the animal rule
- Guidance for industry [electronic resource] : source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans
- Guidance for industry [electronic resource] : Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
- Animal genetics
- Guidance for industry [electronic resource] : considerations for plasmid DNA vaccines for infectious disease indications